Azaindolines
US9340573B2 · kind B2 · utility
0Cited by
0References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 8, 2013 |
| Grant date | May 17, 2016 |
| Priority date | — |
| Expiry date | Oct 8, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein W, Y, Z, R1, R2, R3 and R4 are as described in this application, and methods of using the compounds in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.